- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: T-DM1 or Capecitabine combined with Pyrotinib regimen.
Total 23 results
-
Fudan UniversityRecruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Fudan UniversityActive, not recruitingMetastatic Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesCompleted
-
Jiangxi Provincial Cancer HospitalRecruitingHER2-positive Metastatic Breast CancerChina
-
Fudan UniversityActive, not recruitingBreast Cancer | HER2-positive Breast Cancer | Brain MetastasesChina
-
Peking Union Medical College HospitalRecruitingHER2-positive Breast Cancer | Early-stage Breast CancerChina
-
Dizal PharmaceuticalsActive, not recruitingBreast Cancer MetastaticChina, United States
-
Chongqing University Cancer HospitalNot yet recruitingPARP Inhibitor for Esophageal Squamous Cell Carcinoma
-
Sun Yat-sen UniversityActive, not recruiting
-
Fudan UniversityRecruitingLaryngeal Cancer | Laryngeal Neoplasms | Hypopharynx CancerChina
-
Sichuan Baili Pharmaceutical Co., Ltd.RecruitingNon Small Cell Lung CancerChina
-
Fudan UniversityRecruiting
-
Fudan UniversityActive, not recruitingTNBC - Triple-Negative Breast CancerChina
-
University of California, IrvineNatera, Inc.Not yet recruitingGastroesophageal AdenocarcinomaUnited States
-
Yuhong LiCompletedColorectal Cancer | Chemotherapy-induced NeutropeniaChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | PertuzumabChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruiting
-
Shengjing HospitalNot yet recruiting
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityWithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Ovarian Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Recurrent... and other conditionsUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States